AP NEWS

Dr. Thomas Fountaine of the University of Rochester Medical Center Wilmot Cancer Institute Joins The Assistance Fund’s Medical Advisory Board

November 12, 2018

ORLANDO, Fla.--(BUSINESS WIRE)--Nov 12, 2018--The Assistance Fund, an independent charitable patient assistance foundation that helps patients and families facing high medical out-of-pocket costs, today announced Dr. Thomas Fountaine, Hematologist/Oncologist at the University of Rochester Medical Center Wilmot Cancer Institute, has joined The Assistance Fund’s Medical Advisory Board. Dr. Fountaine serves as an Assistant Professor in Medical Oncology within the Division of Blood and Marrow Transplantation and Medical Director of Stem Cell Processing.

“ Dr. Fountaine is a great addition to our Medical Advisory Board not only because of his many years of patient care experience but also because of his commitment to pursuing medical advancements to improve clinical outcomes and the patient experience,” said Mark P. McGreevy, President and CEO of The Assistance Fund. “Dr. Fountaine is a well-known and respected member of the hematologic and oncologic clinical and research communities and we are grateful that he will be sharing his wealth of knowledge with The Assistance Fund.”

Dr. Fountaine’s research aims to utilize leading-edge technology and genomic tools to accelerate the discovery of novel therapeutic strategies. His research focuses on the translational study of resistant and refractory hematologic diseases and bone marrow failure syndromes, with a particular interest in leukemia, genomics and immunotherapy. He has authored and co-authored a number of papers and book chapters and serves as a peer reviewer for a number of medical journals.

“Being asked to join The Assistance Fund’s Medical Advisory Board is an honor and privilege,” said Dr. Fountaine. “I have spent much of my career researching and utilizing innovative technology and genomic tools to help advance treatment options for patients suffering from difficult-to-treat diseases. The Assistance Fund’s work is a parallel effort to allow more patients to receive life-changing treatment. I am excited to contribute to The Assistance Fund by working alongside the other accomplished physicians on their Medical Advisory Board.”

Dr. Fountaine holds professional memberships with the American Society of Hematology, The American Society of Blood and Marrow Transplantation and The American Society of Clinical Oncology. He received his medical degree from Pennsylvania State University, completed his residency at the University of Rochester Medical Center and completed Fellowship training in hematology/oncology at Johns Hopkins Hospital and the National Institutes of Health/National Cancer Institute.

About The Assistance Fund

The Assistance Fund is an independent charitable patient assistance foundation that helps patients and families facing high medical out-of-pocket costs by providing financial assistance for their copayments, coinsurance, deductibles and other health-related expenses. The Assistance Fund currently manages more than 40 programs – each of which covers the FDA-approved medications that treat a specific disease. Since its founding in 2009, The Assistance Fund has helped more than 73,000 adults and children access the medicines they need to stay healthy or manage a chronic condition. To learn more about The Assistance Fund, or for information on how to donate, please visit tafcares.org.

View source version on businesswire.com:https://www.businesswire.com/news/home/20181112005491/en/

CONTACT: Media

Dan Boyle

Orangefiery

(818) 209-1692

dan@orangefiery.com

KEYWORD: UNITED STATES NORTH AMERICA FLORIDA

INDUSTRY KEYWORD: STEM CELLS HEALTH HOSPITALS ONCOLOGY PHILANTHROPY PROFESSIONAL SERVICES INSURANCE OTHER PHILANTHROPY FDA GENERAL HEALTH MANAGED CARE

SOURCE: The Assistance Fund

Copyright Business Wire 2018.

PUB: 11/12/2018 10:15 AM/DISC: 11/12/2018 10:15 AM

http://www.businesswire.com/news/home/20181112005491/en

AP RADIO
Update hourly